The FDA has approved a new oral drug for the treatment of HR-positive,…
https://www.mbcalliance.org/wp-content/uploads/2023.03-New-Oral.jpg6671000Dana Mooneyhttps://www.mbcalliance.org/wp-content/uploads/mbca-logo.pngDana Mooney2023-03-20 20:29:252023-04-10 20:29:51New oral drug treatment for some advanced breast cancer
Innovative drug offers a novel option for those living with ER+,…
https://www.mbcalliance.org/wp-content/uploads/national-cancer-institute-27uaEym7Kq8-unsplash-scaled-1.jpg438598Dana Mooneyhttps://www.mbcalliance.org/wp-content/uploads/mbca-logo.pngDana Mooney2023-02-08 15:20:482023-02-08 15:20:48New Drug Approved to Treat Metastatic Breast Cancer Patients with ESR1 Mutations
World Cancer Day on February 4 is an international day of awareness…
https://www.mbcalliance.org/wp-content/uploads/Screen-Shot-2023-02-04-at-9.45.33-AM.png14662194Corti Cooperhttps://www.mbcalliance.org/wp-content/uploads/mbca-logo.pngCorti Cooper2023-02-04 09:49:302023-02-06 18:02:56MBC Connect: The Power of Patient Experiences to Transform Treatments & Access to Clinical Trials
New oral drug treatment for some advanced breast cancer
FORCE Syndicated ContentMBC Alliance Announces 2023 Leadership
NewsBlack Wo(Men) Speak Symposium Illuminates Need for Greater Diversity in Clinical Trials
NewsNew Drug Approved to Treat Metastatic Breast Cancer Patients with ESR1 Mutations
NewsMBC Connect: The Power of Patient Experiences to Transform Treatments & Access to Clinical Trials
News